Lawsuit Type Archives: Featured Lawsuit

  • Suboxone Tooth Decay Lawsuit

    Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.

  • Hair Relaxer Lawsuit

    Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.

  • AGGA Lawsuit

    Problems with the AGGA dental device have caused severe teeth damage and disfiguring injuries. Financial compensation may be available through an AGGA lawsuit.

  • Medtronic MiniMed Pump Lawsuit

    Recalled Medtronic MiniMed insulin pumps have been linked to reports of hypoglycemia, hyperglycemia and other serious injuries.

  • RoundUp Lawsuits

    Exposure to RoundUp May Increase Risk of Non-Hodgkins Lymphoma and Other Cancers. Lawsuits Reviewed Nationwide.

  • Sunscreen Cancer Lawsuits

    Leukemia, lymphoma and other cancer may be caused by benzene in Neutrogena, Aveeno, Coppertone and other sunscreens.

  • Tepezza Hearing Loss Lawsuit

    Side effects of Tepezza may cause permanent hearing problems. Lawsuits are being pursued over the drug maker's failure to warn about the risk. Find out if qualify for a settlement.

  • Knee Replacement Lawsuits

    Design problems with several types of knee implants have resulted in lawsuits for individuals who experienced painful complications.

  • Breast Implant Lawsuits

    Women may face a risk of Anaplastic Large Cell Lymphoma (ALCL) from certain breast implants.

  • Enfamil and Similac Baby Formula Lawsuit

    Premature infants fed Similac or Enfamil cow's milk formula faced increased risk of necrotizing enterocolitis (NEC) or wrongful death.

More Top Stories

Camp Lejeune Contaminated Water Lawsuits To Be Selected For Track 1 Bellwether Trials
Camp Lejeune Contaminated Water Lawsuits To Be Selected For Track 1 Bellwether Trials (Posted 5 days ago)

Lawyers will select 25 Camp Lejeune lawsuits involving kidney cancer, bladder cancer, leukemia, non-Hodgkin's lymphoma or Parkinson's disease from a group of 100 eligible cases, which will be prepared for a series of early test trials.